Neuca Clinical Trials Inc., a holding company held by Neuca Group, the proprietor of Clinscience international CRO, has increased its clinical operations in the U.S. by purchasing a 72.6% stake in OncoBay, a Tampa, Florida-based CRO founded by Moffit Cancer Center.
OncoBay is a boutique CRO offering comprehensive, custom-curated solutions for biotechnology companies developing avant-garde immuno-oncology therapies. The company provides unrivaled scientific support and conducts clinical operations in the U.S. with a team of 100+ oncology experts.
